Clinical Trial Update: Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation and expansion study evaluating TROPIKANA, a TROP2-targeted CAR-NK cell therapy engineered with IL-15 and derived from cord blood, in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TROPIKANA (TROP-2 CAR-engineered IL15-transduced cord blood-derived NK cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumors | Phase 1 | Status: RECRUITING